• Ping An Biomedical's class A and class B ordinary shares will undergo a 1-for-40 reverse split effective October 23, 2026.
• Class A ordinary shares are expected to begin split-adjusted trading on Nasdaq that day under the unchanged ticker PASW.
• Outstanding class A ordinary shares will fall to approximately 2,821,675 from 112,867,000, subject to fractional-share rounding.
• Class B ordinary shares outstanding will decline to approximately 306,250 from 12,250,000, subject to fractional-share rounding.
• Fractional share entitlements will be rounded up to the next whole share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610211100PRIMZONEFULLFEED9837292) on October 21, 2026, and is solely responsible for the information contained therein.